CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 75 of 764 entries

View as:

Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town

Phase: N/A Priority: Normal

NCT ID: NCT00460590 Org: User:

Start: 10/31/05 End: 06/30/08 Due: 06/30/09

Eating Concerns and Compulsivity

Phase: N/A Priority: Normal

NCT ID: NCT03450291 Org: User:

Start: 08/18/17 End: 06/01/18 Due: 06/01/19

REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT04916314 Org: User:

Start: 07/01/21 End: 12/31/23 Due: 12/31/24

Monitoring of Perfusion in Sepsis and Malaria

Phase: N/A Priority: Normal

NCT ID: NCT03641534 Org: User:

Start: 06/04/18 End: 09/26/19 Due: 09/26/20

Reward Emotion Learning and Ketamine Study

Phase: N/A Priority: Normal

NCT ID: NCT04850911 Org: User:

Start: 08/25/21 End: 05/31/23 Due: 05/31/24

IMPase in Treatment-resistant Depression

Phase: N/A Priority: Normal

NCT ID: NCT05117710 Org: User:

Start: 04/22/21 End: 05/31/24 Due: 05/31/25

ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses

Phase: N/A Priority: Normal

NCT ID: NCT01682369 Org: User:

Start: 09/30/12 End: 01/31/15 Due: 01/31/16

Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study

Phase: N/A Priority: Normal

NCT ID: NCT02333240 Org: User:

Start: 04/30/15 End: 11/30/16 Due: 11/30/17

A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis

Phase: N/A Priority: Normal

NCT ID: NCT00579956 Org: User:

Start: 12/31/07 End: 09/30/10 Due: 09/30/11

Understanding Pneumococcal Carriage and Disease 2017-2020

Phase: N/A Priority: Normal

NCT ID: NCT03102840 Org: User:

Start: 06/26/17 End: 10/31/20 Due: 10/31/21

Teenage Pregnancies in Refugee and Migrant Adolescents on the Thai-Myanmar Border

Phase: N/A Priority: Normal

NCT ID: NCT02890628 Org: User:

Start: 09/30/16 End: 09/21/16 Due: 09/21/17

A Study of AdCh63 ME-TRAP Alone and With MVA ME-TRAP

Phase: N/A Priority: Normal

NCT ID: NCT00890019 Org: User:

Start: 07/31/07 End: 09/30/11 Due: 09/30/12

Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity

Phase: N/A Priority: Normal

NCT ID: NCT01954563 Org: User:

Start: 10/31/13 End: 01/31/16 Due: 01/31/17

A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants

Phase: N/A Priority: Normal

NCT ID: NCT02083887 Org: User:

Start: 02/28/14 End: 11/30/15 Due: 11/30/16

A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants

Phase: N/A Priority: Normal

NCT ID: NCT03580824 Org: User:

Start: 04/30/19 End: 06/14/22 Due: 06/14/23

A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z

Phase: N/A Priority: Normal

NCT ID: NCT02451891 Org: User:

Start: 04/30/15 End: 08/31/17 Due: 08/31/18

Effects of Dietary Nutrients on Liver and Adipose Tissue Metabolism

Phase: N/A Priority: Normal

NCT ID: NCT03090347 Org: User:

Start: 03/01/17 End: 03/31/23 Due: 03/31/24

Experiment 2: Understanding Liver Fat Metabolism

Phase: N/A Priority: Normal

NCT ID: NCT03587753 Org: User:

Start: 05/01/18 End: 01/01/21 Due: 01/01/22

Study of the Effects of Iron Levels on the Lungs at High Altitude

Phase: N/A Priority: Normal

NCT ID: NCT00952302 Org: User:

Start: 10/31/08 End: 11/30/08 Due: 11/30/09

Outcomes of Neonatal Resuscitation

Phase: N/A Priority: Normal

NCT ID: NCT02840682 Org: User:

Start: 04/30/16 End: 08/15/16 Due: 08/15/17

Simulation-based Arthroscopic Surgery Study

Phase: N/A Priority: Normal

NCT ID: NCT02777333 Org: User:

Start: 01/31/16 End: 07/31/17 Due: 07/31/18

A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination

Phase: N/A Priority: Normal

NCT ID: NCT02362217 Org: User:

Start: 10/31/14 End: 10/31/17 Due: 10/31/18

Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines

Phase: N/A Priority: Normal

NCT ID: NCT00480454 Org: User:

Start: 10/31/06 End: 12/31/09 Due: 12/31/10

Malaria Survey in the Tak Province Refugee Camps

Phase: N/A Priority: Normal

NCT ID: NCT01902797 Org: User:

Start: 07/31/13 End: 12/31/13 Due: 12/31/14

A Study of MVA85A in Healthy Children and Infants

Phase: N/A Priority: Normal

NCT ID: NCT00679159 Org: User:

Start: 02/29/08 End: 12/31/09 Due: 12/31/10

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape Town	NCT00460590	University of Oxford	user2@example.com	None	2005-10-31	2008-06-30	2009-06-30	-	-	2025-07-14
Eating Concerns and Compulsivity	NCT03450291	University of Oxford	user2@example.com	None	2017-08-18	2018-06-01	2019-06-01	-	-	2025-07-14
REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes	NCT04916314	University of Oxford	user2@example.com	None	2021-07-01	2023-12-31	2024-12-31	-	-	2025-07-14
Monitoring of Perfusion in Sepsis and Malaria	NCT03641534	University of Oxford	user2@example.com	None	2018-06-04	2019-09-26	2020-09-26	-	-	2025-07-14
Reward Emotion Learning and Ketamine Study	NCT04850911	University of Oxford	user2@example.com	None	2021-08-25	2023-05-31	2024-05-31	-	-	2025-07-14
IMPase in Treatment-resistant Depression	NCT05117710	University of Oxford	user2@example.com	None	2021-04-22	2024-05-31	2025-05-31	-	-	2025-07-14
ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses	NCT01682369	University of Oxford	user2@example.com	None	2012-09-30	2015-01-31	2016-01-31	-	-	2025-07-14
Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study	NCT02333240	University of Oxford	user2@example.com	None	2015-04-30	2016-11-30	2017-11-30	-	-	2025-07-14
A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis	NCT00579956	University of Oxford	user2@example.com	None	2007-12-31	2010-09-30	2011-09-30	-	-	2025-07-14
Understanding Pneumococcal Carriage and Disease 2017-2020	NCT03102840	University of Oxford	user2@example.com	None	2017-06-26	2020-10-31	2021-10-31	-	-	2025-07-14
Teenage Pregnancies in Refugee and Migrant Adolescents on the Thai-Myanmar Border	NCT02890628	University of Oxford	user2@example.com	None	2016-09-30	2016-09-21	2017-09-21	-	-	2025-07-14
A Study of AdCh63 ME-TRAP Alone and With MVA ME-TRAP	NCT00890019	University of Oxford	user2@example.com	None	2007-07-31	2011-09-30	2012-09-30	-	-	2025-07-14
Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity	NCT01954563	University of Oxford	user2@example.com	None	2013-10-31	2016-01-31	2017-01-31	-	-	2025-07-14
A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants	NCT02083887	University of Oxford	user2@example.com	None	2014-02-28	2015-11-30	2016-11-30	-	-	2025-07-14
A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants	NCT03580824	University of Oxford	user2@example.com	None	2019-04-30	2022-06-14	2023-06-14	-	-	2025-07-14
A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z	NCT02451891	University of Oxford	user2@example.com	None	2015-04-30	2017-08-31	2018-08-31	-	-	2025-07-14
Effects of Dietary Nutrients on Liver and Adipose Tissue Metabolism	NCT03090347	University of Oxford	user2@example.com	None	2017-03-01	2023-03-31	2024-03-31	-	-	2025-07-14
Experiment 2: Understanding Liver Fat Metabolism	NCT03587753	University of Oxford	user2@example.com	None	2018-05-01	2021-01-01	2022-01-01	-	-	2025-07-14
Study of the Effects of Iron Levels on the Lungs at High Altitude	NCT00952302	University of Oxford	user2@example.com	None	2008-10-31	2008-11-30	2009-11-30	-	-	2025-07-14
Outcomes of Neonatal Resuscitation	NCT02840682	University of Oxford	user2@example.com	None	2016-04-30	2016-08-15	2017-08-15	-	-	2025-07-14
Simulation-based Arthroscopic Surgery Study	NCT02777333	University of Oxford	user2@example.com	None	2016-01-31	2017-07-31	2018-07-31	-	-	2025-07-14
A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination	NCT02362217	University of Oxford	user2@example.com	None	2014-10-31	2017-10-31	2018-10-31	-	-	2025-07-14
Safety, Immunogenicity, and Impact of MVA85A, on the Immunogenicity of the EPI Vaccines	NCT00480454	University of Oxford	user2@example.com	None	2006-10-31	2009-12-31	2010-12-31	-	-	2025-07-14
Malaria Survey in the Tak Province Refugee Camps	NCT01902797	University of Oxford	user2@example.com	None	2013-07-31	2013-12-31	2014-12-31	-	-	2025-07-14
A Study of MVA85A in Healthy Children and Infants	NCT00679159	University of Oxford	user2@example.com	None	2008-02-29	2009-12-31	2010-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance